SCHEMBL2352912

SCHEMBL2352912

O=C(N[C@H]1CCCNC1)c1ccc2[nH]cnc2c1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.54
LMNA P02545 1/20 0.54
PBK Q96KB5 3/20 0.54
MAPK1 P28482 1/20 0.50
OPRK1 P41145 1/20 0.50
SMYD3 Q9H7B4 5/20 0.49
HDAC4 P56524 1/20 0.47
SUV39H1 O43463 2/20 0.46
PRMT1 Q99873 2/20 0.46
PARP1 P09874 2/20 0.44
HDAC6 Q9UBN7 1/20 0.43
EPHX1 P07099 1/20 0.43
CHEK1 O14757 1/20 0.43
MLLT1 Q03111 1/20 0.43
KDR P35968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2351583 0.92 NPC1 (0.55) NPC1LMNAPBKSMYD3HDAC4
Hydrochloric Acid SCHEMBL2352408 0.92 NPC1 (0.55) NPC1LMNAPBKSMYD3HDAC4
Hydrochloric Acid SCHEMBL2350435 0.92 NPC1 (0.55) NPC1LMNAPBKSMYD3HDAC4
Hydrochloric Acid SCHEMBL30265427 0.90 NPC1 (0.65) NPC1LMNAPBKMAPK1OPRK1
SCHEMBL3984993 0.88 NPC1 (0.64) NPC1LMNAMAPK1SMYD3HDAC6
Hydrochloric Acid SCHEMBL2356274 0.84 NPC1 (0.60) NPC1LMNASMYD3SUV39H1PRMT1
SCHEMBL8313317 0.83 NPC1 (0.51) NPC1LMNAPBKSMYD3HDAC6
Hydrochloric Acid SCHEMBL2350440 0.82 NPC1 (0.67) NPC1LMNASMYD3SUV39H1PRMT1
Hydrochloric Acid SCHEMBL30265463 0.82 NPC1 (0.67) NPC1LMNASMYD3SUV39H1PRMT1
SCHEMBL5797061 0.80 ULK1 (0.40) NPC1LMNAPBKHDAC6EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011103018-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF HIGH POINT PHARMACEUTICALS, LLC (US) 2011-08-25 WO disclosed